Digitek Caraco Digoxin Recall | Free Consultation
Caraco Digoxin Recall
FDA Digitek Recall
Side Effects
Digitalis Digoxin Toxicity Deaths
UDL Digoxin Recall
Bertek Recall
Digitek Recall News Updates
Digitek Lawyer - Board Certification Houston, Texas
Digitek Attorneys -  Houston, Texas Law Firm
Digitek Recall Lawyer Attorney
Disclaimers & Notices
Class Action Lawsuit Lawyer
Free Lawsuit  Evaluation
Caraco Digoxin Recall & Digitek Recall Lawsuits 

Caraco Digoxin Recalled by FDA - RECALL NEWS ALERT

Caraco Pharmaceutical Laboratories, a generic pharmaceutical company, announced today that all tablets of Caraco brand Digoxin, USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of September, 2011, are being voluntarily recalled to the consumer level. The tablets are being recalled because they may differ in size and therefore could have more or less of the active ingredient, digoxin. READ MORE: Caraco Digoxin Recall

Digitek Overdose - Digoxin Toxicity Death Lawsuits

DigitekŪ (Digoxin) is used to treat conditions such as congestive heart failure and atrial fibrillation/atrial flutter (types of fast heartbeats). Digoxin helps the heart to beat more strongly and regularly. However double the prescribed amount of digoxin, the active ingredient in Digitek can cause a risk of digitalis toxicity in patients. Even a single Digitek overdosage can be fatal and can cause digoxin toxicity. Those Digitek users suffering from renal failure are at risk even a higher risk of digitalis toxicity because they cannot excrete digitalis from their bodies like healthy people.

Talk to a Lawyer. Get a Free Digitek Lawsuit Evaluation

Digitek, Bertek & UDL Digoxin Recalled by FDA

Morristown, NJ -- April 25, 2008 -- Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, is initiating a Class I nationwide recall of DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. (See:FDA Recall of Digitek.)

The voluntary "all lots" recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. These tablets were slightly thicker due to an extra coating and may contain two times the approved level of active ingredient than it appropriate.

DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake. FDA has received many reports of serious illnesses and injuries regarding digitalis toxicity. (See:Digitek Overdose Side Effects)

Digitek Lawsuit News Update

Digoxin Injury & Digitek Wrongful Death Lawsuit - Contact a Digitek Lawyer

If you or a loved one have been seriously injured or a loved one has died as a result of digitalis toxicity or an overdose of Digitek, Bertek brand Digoxin and/or UDL Digoxin, please contact immediately for a Free Digitek Lawsuit Evaluation or call us at 1-800-883-9858.

Nationwide Help is Available

Caraco Digitek Digoxin Toxicity, Digitalis Toxicity Overdose Lawsuits and Digetek Caraco Recall Deaths - Digoxin / Digitalis Toxicity.


   

  Board Certified Trial Lawyer            Nationwide Help          AV- Highest Rating Available

       FDA RECALL- Raptiva has been recalled due to increased PML Brain infections and meningitis. See: Raptiva Recall and PML Lawsuit for more Raptiva recalled info.                           

 

 

______________________________________________________________________________________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Digoxin is used to treat congestive heart failure and atrial fibrillation, "A- Fib", atrial flutter (types of fast heartbeats). Digoxin helps the heart to beat more strongly and regularly. However double the prescribed amount of digoxin, the active ingredient in Digitec can cause a risk of digitalis toxicity in normal cardiac patients and especially in patients being treated for renal (kidney) failure. Digetek is a registered trademark of ActavisTotawa and distributed by Mylan Pharmaceuticals, Inc., with a "Bertek" label and by UDL Laboratories, Inc. with a "UDL" label. FDA digitech recall information and digetec recall news and updates. Talk to a Digitek Lawsuit Lawyer about filing a digitec recall Lawsuit or about the details of a possible digetek class action lawsuit. Free Case Evaluation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Site Powered By
    HoustonsHost SiteBuilder
    Online web site design